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Abstract
Introduction: Hypothermia improves survival and neurological recovery after cardiac arrest. Pro-inflammatory
cytokines have been implicated in focal cerebral ischemia/reperfusion injury. It is unknown whether cardiac arrest
also triggers the release of cerebral inflammatory molecules, and whether therapeutic hypothermia alters this
inflammatory response. This study sought to examine whether hypothermia or the combination of hypothermia
with anesthetic post-conditioning with sevoflurane affect cerebral inflammatory response after cardiopulmonary
resuscitation.
Methods: Thirty pigs (28 to 34 kg) were subjected to cardiac arrest following temporary coronary artery occlusion.
After seven minutes of ventricular fibrillation and two minutes of basic life support, advanced cardiac life support
was started according to the current American Heart Association guidelines. Return of spontaneous circulation was
achieved in 21 animals who were randomized to either normothermia at 38°C, hypothermia at 33°C or
hypothermia at 33°C combined with sevoflurane (each group: n = 7) for 24 hours. The effects of hypothermia and
the combination of hypothermia with sevoflurane on cerebral inflammatory response after cardiopulmonary
resuscitation were studied using tissue samples from the cerebral cortex of pigs euthanized after 24 hours and
employing quantitative RT-PCR and ELISA techniques.
Results: Global cerebral ischemia following resuscitation resulted in significant upregulation of cerebral tissue
inflammatory cytokine mRNA expression (mean ± SD; interleukin (IL)-1b 8.7 ± 4.0, IL-6 4.3 ± 2.6, IL-10 2.5 ± 1.6,
tumor necrosis factor (TNF)a 2.8 ± 1.8, intercellular adhesion molecule-1 (ICAM-1) 4.0 ± 1.9-fold compared with
sham control) and IL-1b protein concentration (1.9 ± 0.6-fold compared with sham control). Hypothermia was
associated with a significant (P < 0.05 versus normothermia) reduction in cerebral inflammatory cytokine mRNA
expression (IL-1b 1.7 ± 1.0, IL-6 2.2 ± 1.1, IL-10 0.8 ± 0.4, TNFa 1.1 ± 0.6, ICAM-1 1.9 ± 0.7-fold compared with
sham control). These results were also confirmed for IL-1b on protein level. Experimental settings employing
hypothermia in combination with sevoflurane showed that the volatile anesthetic did not confer additional anti-
inflammatory effects compared with hypothermia alone.
Conclusions: Mild therapeutic hypothermia resulted in decreased expression of typical cerebral inflammatory
mediators after cardiopulmonary resuscitation. This may confer, at least in part, neuroprotection following global
cerebral ischemia and resuscitation.
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Although initial return of spontaneous circulation (ROSC)
from cardiac arrest is achieved in about 30 to 40% of
cases, only 10 to 30% of the patients admitted to the hos-
pital will be discharged with good outcome [1]. One third
of those who survive, suffer persistent neurological impair-
ments [2]. Mild therapeutic hypothermia has emerged as
the most effective strategy to reduce neurological impair-
ment after successful cardiopulmonary resuscitation (CPR)
[3]. The precise mechanisms by which mild hypothermia
protects brain cells remain to be elucidated, but it is very
likely that hypothermia acts upon multiple pathways
including reduction in cerebral metabolism and oxygen
consumption, attenuation of neuronal damage, and inhibi-
tion of excitatory neurotransmitter release [4].
There is growing evidence on the damaging nature of
the inflammatory response following brain ischemia.
Various inflammatory cytokines have been implicated as
important mediators of ischemia/reperfusion injury fol-
lowing both focal and global cerebral ischemia [5]. Most
of the previous experimental studies induced global cer-
ebral ischemia by bilateral carotid artery occlusion as a
correlate of cardiac arrest, but inflammatory response
mechanisms following carotid artery occlusion and anti-
inflammatory mechanisms of hypothermia may be dif-
ferent from those observed after cardiac arrest and man-
ual CPR. Thus, it is unknown whether cardiac arrest
also triggers the release of cerebral inflammatory mole-
cules, and whether therapeutic hypothermia alters this
inflammatory response.
Neuronal injury may also result in necrotic and apop-
totic cell death. In contrast to necrosis (cell death by
acute injury), apoptosis is a well-regulated physiological
process. Cells undergoing apoptosis are characterized by
cytoplasmic shrinkage, nuclear condensation, and forma-
tion of membrane-bound vesicles. Key elements of the
apoptotic pathway include changes in the gene expres-
sion of the pro-apoptotic protein Bax and the apoptosis-
suppressing protein Bcl-2. The extent to which
hypothermia affects cerebral apoptosis-related proteins
after successful CPR is not clear [4].
The mismatch between early survival and final out-
come after CPR emphasizes the importance of further
research on potential adjuvants in addition to mild
hypothermia. Specifically, pharmacological post-condi-
tioning may offer an attractive opportunity to further
ameliorate damage to the brain in the post-resuscitation
period. While the volatile anesthetic sevoflurane has
emerged as a pre-conditioning-like agent with significant
neuroprotective effects in models of focal and global
cerebral ischemia [6], its potential neuroprotective and
anti-inflammatory properties have not yet been investi-
gated in the context of post-resuscitation care. Thus, a
combination of hypothermia and anesthetic post-condi-
tioning with sevoflurane may extend neuroprotection, as
it has recently been shown for the noble anesthetic gas
xenon combined with hypothermia after neonatal
hypoxia-ischemia [7].
We hypothesized that hypothermia attenuates cerebral
inflammatory response in a pig model of global cerebral
ischemia following cardiac arrest. We further hypothe-
sized that the volatile anesthetic sevoflurane, when
administered during reperfusion after successful CPR,
confers additional anti-inflammatory effects.
Materials and methods
The project was approved by the Animal Investigation
Committee of the University Schleswig-Holstein, Cam-
pus Kiel, Germany, and animals were managed in accor-
dance with the guidelines of the University Schleswig-
Holstein, Campus Kiel, Germany, and the Utstein-style
guidelines [8]. All animals received human care in com-
pliance with the Guide for the Care and Use of Labora-
tory Animals published by the National Institute of
Health (NIH Publication No. 88.23, revised 1996).
Animals
This is an experimental study on 40 healthy pigs (car-
diac arrest: n = 30; sham control: n = 5; excluded from
study n = 5) aged three to four months of both gender,
weighing 28 to 34 kg. Anesthesia was initiated by intra-
muscular injection of 8 mg/kg azaperone and 0.05 mg/
kg atropine, and completed by intravenous injection of
1t o2m g / k gp r o p o f o la n d0 . 3μg/kg sufentanil. After
endotracheal intubation, pigs were ventilated with a
volume-controlled ventilator (Draeger, Sulla 808V, Lue-
beck, Germany) and the following setting: a FiO2 of 0.3
at 20 breaths/minute, a tidal volume of 8 mL/kg to
maintain normocapnia, and a positive end-expiratory
pressure of 5 mm Hg. Ventilation was monitored using
an inspired/expired gas analyzer that measured oxygen
and end-tidal carbon dioxide (suction rate, 200 mL/min;
M-PRESTN; Datex-Ohmeda Inc., Helsinki, Finland).
Total intravenous anesthesia (TIVA) was maintained by
continuous infusion of 4 to 8 mg/kg/h propofol and 0.3
μg/kg/h sufentanil; muscle relaxation was achieved by
continuous infusion of 0.2 mg/kg/h pancuronium.
Depth of anesthesia was judged according to blood pres-
sure, heart rate and Bispectral Index (BISXP, Aspect
Medical Systems, Natick, MA, USA) [9]. In order to
assure an appropriate depth of anesthesia we performed
also indirect measures such as tail clamping, monitoring
of the corneal reflex and lacrimation, as well as changes
in hemodynamics and heart rate. If assessment sug-
gested inadequate level of anesthesia, additional sufenta-
nil and propofol was injected. Ringer’ss o l u t i o nw a s
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phase to replace fluid loss during instrumentation. Stan-
dard leads II and V5 electrocardiogram were used to
monitor cardiac rhythm.
A 7F saline-filled central venous catheter was inserted
in the right internal jugular vein for drug administration.
A 4F thermistor-tipped catheter for arterial thermodilu-
tion (Pulsion Medical Systems, Munich, Germany) was
inserted percutaneously into the right femoral artery.
The arterial catheter was connected to the PiCCO sys-
tem (PiCCO plus, Software Version 6.0, Pulsion Sys-
tems, Munich, Germany), and the resulting signal
processed to determine mean arterial blood pressure,
heart rate, and blood temperature. In addition, the arter-
ial catheter allowed discontinuous measurement of
transpulmonary cardiac output by injecting 10 mL ice
cold saline into the proximal port of the central venous
catheter. The mean of three consecutive measurements
randomly assigned to the respiratory cycle was used for
determination of cardiac output. Cardiac index was cal-
culated as the ratio of cardiac output/body surface area
(body surface area = 0.0734*(body weight in kg)
0.656
[10]). Intravascular catheters were attached to pressure
transducers (Smiths Medical, Kirchseeon, Germany) that
were aligned at the level of the right atrium.
Experimental protocol
The experimental time line is presented in Figure 1.
Because the majority of patients experience cardiac
arrest due to myocardial ischemia [11], and because this
scenario has only been considered in few animal experi-
ments, our study is based on an experimental porcine
model of cardiac arrest following acute coronary artery
ischemia reflecting a realistic clinical setting. Five
healthy animals served as sham controls, which were
anesthetized with TIVA until the end of the experiment.
Thirty-five pigs underwent left anterior descending
(LAD) coronary artery occlusion for 60 minutes accord-
ing to the technique previously described [12]. Five pigs
fibrillated spontaneously following left anterior descend-
ing coronary artery occlusion, which were excluded
from further analysis. Thirty pigs were then subjected to
cardiac arrest 20 minutes after LAD occlusion. Ventri-
cular fibrillation was electrically-induced by an alternat-
ing current of 5 to 10 V in a standardized manner, and
mechanical ventilation was discontinued. After a seven-
minute non-intervention interval of untreated ventricu-
lar fibrillation, basic life support CPR was simulated for
two minutes applying external manual closed chest
compressions at a rate of 100 per minute, and a com-
pression-to-ventilation ratio of 30:2. Subsequently,
advanced cardiac life support was started with 100 J
biphasic defibrillation attempt (M-Series Defibrillators,
Zoll Medical Corporation, Chelmsford, Massachusetts,
USA), all subsequent attempts were performed with 150
J every two minutes. Ventilations were performed with
100% oxygen at 20 breaths/minute. All pigs received 45
μg/kg epinephrine and 0.4 U/kg vasopressin alternating
as suggested by the American Heart Association guide-
lines [13]. ROSC was defined as maintenance of an
u n a s s i s t e dp u l s ea n das y s t o l i ca o r t i cb l o o dp r e s s u r eo f
≥60 mm Hg lasting for 10 consecutive minutes accord-
ing to the Utstein-style guidelines [8]. Since neurological
recovery is very unlikely after 30 minutes of normother-
mic cardiac arrest, CPR was terminated, when resuscita-
tion remained unsuccessful after 23 minutes of CPR.
After ROSC, animals were randomized either to nor-
mothermia (38°C) plus TIVA (NT), hypothermia (33°C)
plus TIVA (HT), or hypothermia (33°C) combined with
2.0 Vol% end-tidal sevoflurane and 0.3 μg/kg/h sufenta-
nil (HT+SEV). Since hypothermia was shown to increase
blood concentrations of propofol by about 30% [14], we
reduced continuous infusion of propofol during
hypothermia targeting bispectral index values below 60.
Body core temperature was monitored continuously by
the arterial catheter, and normothermic body tempera-
ture was maintained at 38.0°C with a heating blanket,
since the physiological rectal temperature of pigs is sup-
posed to be about 38°C [15]. Hypothermia was induced
by 1,000 mL saline (4°C) and maintained by a cooling
device (Icy catheter and CoolGard 3000; Alsius Corp,
Irvine, CA, USA) that was introduced into the femoral
vein. According to the landmark study by Bernard et al.
[16] we used a target body temperature of 33°C for 12
hours. Thereafter, re-warming was initiated (0.5°C per
hour). One hour after ROSC, FiO2 was reduced to 0.4.
During the post-resuscitation period, animals received
crystalloid infusions to keep central venous pressure
above 8 mm Hg and mean arterial blood pressure above
50 mm Hg. If this first step failed, additional norepi-
nephrine was administered to keep mean arterial blood
pressure above 50 mm Hg. We further aimed at serum
glucose levels less than 150 mg/dL by intermittent insu-
lin bolus administration. Animals were killed by an
overdose of sufentanil, propofol and potassium chloride
24 hours after ROSC. Tissue samples of the cerebral
cortex were collected within 15 seconds following eutha-
nasia via ac r a n i o t o m yt h a tw a se s t a b l i s h e db e f o r e
euthanasia, and then immediately snap-frozen in liquid
nitrogen (stored at -80°C) to minimize time-dependent
effects of cerebral ischemia following euthanasia on
cytokine expression. Autopsy was routinely performed
for documentation of potential injuries to the thoracic
and abdominal cavity during CPR.
Hemodynamic data, including mean arterial blood
pressure, heart rate, end-tidal carbon dioxide, and car-
diac index were determined at baseline (BL), following
ROSC, and 7 and 24 hours after ROSC, respectively.
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Transcript levels of interleukin (IL)-1b,I L - 6 ,I L - 1 0 ,
tumor necrosis factor (TNF)a, intercellular adhesion
molecule (ICAM)-1, and the apoptosis-associated pro-
teins Bcl-2 and Bax were investigated in the cerebral
cortex tissue of all surviving animals and compared with
tissue of sham control animals. Tissue samples were
analyzed by a person blinded to treatment assignment.
Fully detailed description of quantitative real-time RT-
PCR is presented in the Additional File 1 and Table S1
[17-20].
Enzyme-linked immunosorbent assay (ELISA)
Protein concentrations of IL-1b were determined by a
swine specific ELISA (BioSource International, Inc.
Camarillo, CA, USA) in homogenates of frozen tissues
according to the manufacturer’sp r o t o c o l .A l lE L I S A
assays were carried out in duplicates.
Statistical analysis
Statistics were performed using commercially available
statistics software (GraphPad Prism version 5.02 for
Windows, GraphPad Software, San Diego, CA, USA).
Survival rates were compared using Fisher’s exact test.
Statistical analysis was performed with a one-way analy-
sis of variance (ANOVA) followed by a Bonferroni post
hoc test to correct for multiple measurements. RT-PCR
data analysis was performed according to a relative stan-
dard curve method using an Excel spreadsheet, and sta-
tistical significance was tested using two-sided Pair-wise
fixed Reallocation Randomisation Test, as provided in
the REST2005 program [20]. The Mann-Whitney test
was used for analysis of protein concentrations of IL-1b
where normal distribution was not expected. Variables
are expressed as mean ± SD unless otherwise specified.
Statistical significance was considered at a two-sided P
value of ≤ 0.05.
Results
Cardio-pulmonary resuscitation
Twenty-one animals were successfully resuscitated.
Detailed resuscitation data are presented in Table 1. In
the NT group, five out of seven animals survived for 24
hours compared to all animals in the HT and HT+SEV
group (P = 0.46 vs. NT). Two animals of the NT group
died due to hemodynamic instability during the post-
resuscitation period.
Post-resuscitation hemodynamics
Post-resuscitation systemic hemodynamic variables are
presented in Table 2. Heart rate, mean arterial blood
pressure and cardiac index did not significantly differ
between groups. Cumulative crystalloid fluid load and
cumulative norepinephrine doses were not significantly
different between groups 24 hours after ROSC (volume
load (P = 0.540), norepinephrine doses (P =0 . 8 1 2 ) ;N T :
4241 ± 1244 mL, 4.4 ± 1.6 mg; HT: 3987 ± 932 mL, 4.9
± 2.1 mg; HT+SEV: 4627 ± 1056 mL, 5.1 ± 1.8 mg).
Cerebral inflammatory response
Global cerebral ischemia following resuscitation
resulted in a significant upregulation of cerebral tissue
inflammatory cytokine mRNA expression (NT: IL-1b
8.7 ± 4.0, IL-6 4.3 ± 2.6, IL-10 2.5 ± 1.6, TNFa 2.8 ±
1.8, ICAM-1 4.0 ± 1.9-fold compared with sham con-
trol) and IL-1b protein concentration (1.9 ± 0.6-fold
compared with sham control). Hypothermia was
associated with significantly (P <0 . 0 5v e r s u s
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Figure 1 Experimental time line. Thirty pigs were subjected to cardiac arrest following left anterior descending (LAD) coronary artery ischemia.
Ventricular fibrillation (VF) was electrically induced twenty minutes after LAD occlusion. After seven minutes of VF, pigs were resuscitated (CPR).
After successful return of spontaneous circulation (ROSC; n = 21), coronary perfusion was reestablished after 60 minutes of LAD occlusion, and
animals were randomized either to normothermia at 38°C, hypothermia at 33°C or hypothermia at 33°C combined with sevoflurane (each group
n = 7) for 24 hours. Five animals were sham operated. In the normothermia group, five out of seven animals survived for 24 hours compared to
all animals in the hypothermia and hypothermia combined with sevoflurane group.
Meybohm et al. Critical Care 2010, 14:R21
http://ccforum.com/content/14/1/R21
Page 4 of 11normothermia) less upregulation of mRNA expression
(IL-1b 1.7 ± 1.0, IL-6 2.2 ± 1.1, IL-10 0.8 ± 0.4, TNFa
1.1 ± 0.6, ICAM-1 1.9 ± 0.7-fold compared with sham
control) and IL-1b protein concentration (1.3 ± 0.4-
fold compared with sham control). Sevoflurane did not
confer statistically significant (versus hypothermia)
additional protective effects neither on mRNA (IL-1b
1.2 ± 0.6, IL-6 2.0 ± 0.9, IL-10 0.7 ± 0.3, TNFa 0.9 ±
0.4, ICAM-1 1.8 ± 0.6-fold compared with sham con-
trol) nor on protein levels (1.1 ± 0.2-fold compared
with sham control; Figures 2 and 3).
Bax and Bcl-2 mRNA expression
W ef o u n das i g n i f i c a n t( P < 0.01) upregulation of both
Bcl-2 mRNA and Bax expression after global cerebral
ischemia (NT: Bcl-2 3.2 ± 1.8-fold, Bax 2.3 ± 1.3-fold
compared with sham control). Hypothermia was asso-
ciated with significantly (P < 0.05) less upregulation of
mRNA expression (Bcl-2 1.2 ± 0.5-fold, Bax 1.2 ± 0.6-
fold compared with sham control). Sevoflurane did not
confer additional effects (Bcl-2 1.1 ± 0.4-fold, Bax 1.1 ±
0.4-fold compared with sham control; Figure 4).
Discussion
Neurological dysfunction resulting from cardiac arrest
largely contributes to morbidity and mortality after initi-
ally successful CPR [21]. Employing a pig model we
showed that (i) global cerebral ischemia following car-
diac arrest and CPR results in upregulation of pro-
inflammatory cytokine expression in the cerebral tissue,
ii) mild hypothermia significantly reduces cerebral tissue
inflammatory response, and (iii) pharmacological post-
conditioning with sevoflurane does not confer additional
anti-inflammatory effects on cerebral tissue.
Cerebral inflammatory response following resuscitation
Mechanisms of brain injury following cerebral ischemia
are complex with multiple modulators, signaling path-
ways, proteins and enzymes being involved that may
facilitate cell death or survival [22]. Post-ischemic
inflammation has been shown to play a critical role in
cerebral ischemia/reperfusion injury [23]. Specifically,
there is strong evidence suggesting that a disproportion-
ate and persistent production of cytokines can signifi-
cantly increase the risk and extent of brain injury [5,24].
In terms of a systemic inflammatory response, increased
serum levels of different cytokines and chemokines have
recently been presented in a rat model of cardiac arrest
[25], and in patients successfully resuscitated from out-
of-hospital cardiac arrest [26,27]. The role of the cere-
bral inflammatory response after cardiac arrest, however,
Table 1 Cardiopulmonary resuscitation data
NT HT HT+SEV P values
ROSC rate [n] 7/10 7/10 7/10 -
CPR time to successful resuscitation [min] 9.7 ± 2.8 10.3 ± 3.4 10.5 ± 3.1 0.939
Cumulative epinephrine dose [μg/kg] 100 ± 44 101 ± 47 93 ± 33 0.828
Cumulative vasopressin dose [IU/kg] 0.8 ± 0.2 0.8 ± 0.3 0.8 ± 0.3 0.897
Cumulative defibrillation energy [J] 755 ± 420 703 ± 413 795 ± 199 0.854
CorPP 10 [mm Hg] 31 ± 9 26 ± 11 28 ± 6 0.559
CorPP 15 [mm Hg] 39 ± 28 40 ± 25 38 ± 24 0.890
Time to target temperature 33°C [min] - 47 ± 10 45 ± 15 -
ROSC, return of spontaneous circulation; CPR, cardiopulmonary resuscitation. Time to successful resuscitation, cumulative epinephrine and vasopressin dose,
cumulative defibrillation energy, coronary perfusion pressure (CorPP) 10 and 15 minutes after induction of ventricular fibrillation, and induction time to target
temperature of 33°C. NT indicates normothermia; HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane. Data are mean ± SD.
Table 2 Hemodynamic data
NT HT HT+SEV P value
Baseline
HR, beats/minute 107 ± 21 105 ± 14 96 ± 15 0.342
MAP, mm Hg 65 ± 13 70 ± 11 71 ± 13 0.314
ETCO2, mm Hg 40 ± 5 36 ± 4 37 ± 5 0.180
CI, L/min/m
2 7.4 ± 1.8 6.8 ± 1.3 7.4 ± 1.7 0.580
ROSC
HR, beats/minute 94 ± 18 99 ± 33 96 ± 21 0.988
MAP, mm Hg 55 ± 6 65 ± 21 60 ± 8 0.225
ETCO2, mm Hg 39 ± 9 42 ± 4 39 ± 7 0.363
CI, L/min/m
2 4.4 ± 0.5 4.5 ± 1.9 4.6 ± 1.0 0.982
Seven hours ROSC
HR, beats/minute 131 ± 17 140 ± 22 127 ± 20 0.821
MAP, mm Hg 58 ± 4 59 ± 12 61 ± 8 0.820
ETCO2, mm Hg 37 ± 7 35 ± 4 35 ± 2 0.731
CI, L/min/m
2 6.2 ± 0.4 5.5 ± 1.1 7.1 ± 1.2 0.071
24 hours ROSC
HR, beats/minute 154 ± 25 143 ± 19 124 ± 24 0.297
MAP, mm Hg 46 ± 6 57 ± 12 54 ± 4 0.249
ETCO2, mm Hg 37 ± 4 41 ± 1 37 ± 2 0.180
CI, L/min/m
2 5.6 ± 0.2 7.1 ± 1.6 8.7 ± 1.8 0.139
Hemodynamic data were determined at baseline, following return of
spontaneous circulation (ROSC), and 7 and 24 hours after ROSC. HR indicates
heart rate; MAP, mean arterial blood pressure; ETCO2, end-tidal carbon
dioxide, CI, cardiac index; NT, normothermia; HT, hypothermia; HT+SEV,
hypothermia combined with sevoflurane. Data are mean ± SD.
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experimental studies induced global cerebral ischemia
by bilateral carotid artery occlusion as a surrogate of
cardiac arrest, but inflammatory response mechanisms
following carotid artery occlusion and anti-inflammatory
mechanisms of hypothermia are different from the ones
observed after cardiac arrest and resuscitation [27].
Youngquist et al. [28] have recently shown increased
TNFa and IL-6 protein concentration in the
cerebrospinal fluid following cardiac arrest. Since the
presence of a lesion pattern of cortical involvement,
termed as extensive cortical lesion pattern in MR ima-
ging, has very recently been shown to be a very good
predictor of poor neurologic prognosis after cardiac
arrest [29], we focused on neuroinflammation in the
cerebral cortex tissue. In our study, global cerebral
ischemia following cardiac arrest resulted in a significant
upregulation of mRNA expression of several cytokines
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Figure 2 Cerebral cytokine mRNA expression. Transcript levels of the cerebral cytokines interleukin (IL)-1b, IL-6, IL-10, tumor necrosis factor
(TNF)a and intercellular adhesion molecule (ICAM)-1 were determined by quantitative RT-PCR. NT, normothermia; HT, hypothermia; HT+SEV,
hypothermia combined with sevoflurane. Data are expressed as mean ± SD (x-fold upregulation compared with Sham control). * P < 0.05, † P <
0.01 vs. Sham. §P < 0.05, #P < 0.01 vs. NT. RT-PCR data analysis was performed using two-sided Pair-wise fixed Reallocation Randomisation Test.
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Figure 3 Protein concentration of interleukin-1b. Protein concentration of interleukin (IL)-1b was determined by a swine specific enzyme-
linked-immunosorbent assay. NT, normothermia; HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane. Data are expressed as
mean ± SD (x-fold upregulation compared with Sham control). *P < 0.05 vs. Sham. §P < 0.05, #P < 0.01 vs. NT (using Mann-Whitney test).
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Page 6 of 11in the cerebral cortex tissue. In addition, we observed a
significant rise in IL-1b protein concentration in the
cerebral cortex tissue that may be most probably due to
local synthesis primarily by microglial cells, astrocytes
and/or endothelial cells [30] rather than transport across
the blood-brain barrier. This is emphasized by the data
of Mizushima and colleagues who demonstrated that
the integrity of the blood-spinal cord and blood-brain
barriers to radiolabelled TNFa remains intact following
resuscitation in a mouse model of cardiac arrest [31].
Effects of hypothermia on cerebral inflammatory
response
Several mechanisms by which hypothermia exerts its
protective effects have been characterized, including
reduction in excitotoxin accumulation and inhibition of
molecular pathways such as apoptosis and necrosis [4].
The role of inflammation in global cerebral ischemia
induced by bilateral carotid artery occlusion and focal
cerebral ischemia has extensively been studied, but
effects of hypothermia on global cerebral ischemia/
reperfusion injury following cardiac arrest has been
investigated to a much lesser extent. Webster et al. have
previously found that mild hypothermia attenuated
microglial activation and nuclear translocation of NFB,
and thereby reduced activation of the downstream
inflammatory pathway [32]. Considering the relatively
late onset of the inflammatory response and the pro-
longed destructive process following cerebral ischemia/
reperfusion, there appears to be a reasonable therapeutic
time window using mild hypothermia to favourably
affect the inflammatory pathway [33]. To date, the
majority of publications may suggest that hypothermia
simply blocks any ischemia-induced damaging cascade.
However, contrary to this popular belief, the expression
of certain beneficial genes is actually upregulated by
mild hypothermia [4]. Hicks and colleagues [34] further
demonstrated that prolonged hypothermia during later
reperfusion improved neurological outcome after experi-
mental global ischemia and was associated with selective
changes in the pattern of stress-induced protein expres-
sion. From our data we conclude that mild hypothermia
initiated after successful resuscitation from cardiac
arrest reduces pro-inflammatory cytokine, IL-10, and
ICAM-1 mRNA expression compared to normothermia.
Inhibition of adhesion molecule expression and micro-
glial activation has also been confirmed by Deng and
colleagues in rat models of both focal cerebral ischemia
and brain inflammation [35]. Thus, the beneficial effects
of hypothermia on neuroprotection are considered to be
due, in part, to suppression of post-injury pro-inflamma-
tory factors by microglia. However, the role of hypother-
mia in modulating anti-inflammatory cytokines, for
example, IL-10, remains controversial. While mild
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Figure 4 Cerebral Bcl-2 and Bax mRNA expression. Transcript levels of the cerebral apoptosis-associated proteins Bcl-2 and Bax were
determined by quantitative RT-PCR. NT, normothermia; HT, hypothermia; HT+SEV, hypothermia combined with sevoflurane. Data are expressed
as mean ± SD (x-fold upregulation compared with Sham control). *P < 0.05 vs. Sham. §P < 0.05 vs. NT. RT-PCR data analysis was performed
using two-sided Pair-wise fixed Reallocation Randomisation Test.
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concentration in endotoxemic rats, thus potentially
mediating the anti-inflammatory effects of hypothermia
[36,37], Matsui et al. [38] and Russwurm et al. [39] have
previously demonstrated that mild hypothermia inhibits
IL-10 production in peripheral blood mononuclear cells.
Interestingly, in lipopolysaccharide-activated cultured
microglia cells isolated from rats, hypothermia has also
been found to reduce production of IL-6, IL-10, and
nitric oxide, suggesting that the neuroprotective effects
of hypothermia might involve not only the inhibition of
pro-inflammatory factors, but also the inhibition of anti-
inflammatory factor(s) [40]. Comparably, we found less
upregulation of IL-10 mRNA expression in the cerebral
tissue in the hypothermia group compared to nor-
mothermia after successful CPR.
Since IL-1b was one of the cytokines that was strongly
up-regulated on mRNA level in our study, we decided
to evaluate IL-1b expression also on the protein level.
Analysis of cerebral cortex tissue using a swine specific
ELISA system revealed significantly increased IL-1b pro-
tein concentration compared with the sham control
group after cardiac arrest and normothermia but not
after hypothermia. Interestingly, Callaway et al. have
recently demonstrated that hypothermia after cardiac
arrest did not alter serum inflammatory markers, sug-
gesting that circulating cytokines may not play a specific
role regarding the neuroprotective effect of hypothermia
[25]. In contrast, it is well conceivable, that local cere-
bral cytokines released by brain cells will affect more
extensively various cerebral ischemia/reperfusion injury
cascades and will have a much broader effect on brain
damage than systemically elevated levels of cytokines.
Concerning reliable biochemical markers of brain tis-
sue damage, increased serum levels of the low molecular
weight protein S100B have been reported after cardiac
arrest correlating with neurological complications. How-
ever, mild therapeutic hypothermia did not affect S100B
serum levels in survivors of cardiac arrest in several
clinical studies [41,42]. In addition, Xiao and colleagues
have previously shown that cardiac arrest significantly
increased brain myeloperoxidase activity, but again, mild
hypothermia had no effect. Thus, the hypothermia-eli-
cited neuroprotection seemed not to be neutrophil-
dependent, at least in that rat model of asphyxial cardiac
arrest [43].
Effects of pharmacological post-conditioning on cerebral
inflammatory response
Volatile anesthetic agents have emerged as pre-condi-
tioning-like agents with significant neuroprotective
effects and the ability to reduce excitotoxic induced cell
death, to decrease cerebral metabolic rate, to activate
i n d u c i b l en i t r o u so x i d es y n t h a s ea n dp 3 8m i t o g e n -
activated protein kinases, and to improve neurological
deficits in models of both focal and global cerebral
ischemia [6,44,45]. Most experimental studies have
documented improved functional performance when
neuroprotective agents were given before the insult. In
patients with cardiac arrest, however, pretreatment is
v i r t u a l l yi m p o s s i b l eb e c a u s eo f the unpredictable onset
of ischemia. Therefore, as in our study, potential protec-
tive interventions should be initiated during or after
experimental ischemia to affect reperfusion injury. In
this context, pharmacological postconditioning with
volatile anesthetics in addition to mild hypothermia may
offer an attractive opportunity to further ameliorate
brain damage and inflammation in the post-resuscitation
period. The effects of volatile agents on the inflamma-
tory response after cardiac arrest have not yet been elu-
cidated. In endotoxemic rats, inhalation of sevoflurane
significantly attenuated plasma levels of TNFa and IL-
1b [46]. In addition, sevoflurane post-conditioning
showed anti-inflammatory and anti-necrotic effects in
cultured kidney proximal tubule cells [47], and sevoflur-
ane attenuated the inflammatory response upon stimula-
tion of alveolar macrophages with endotoxin in vitro
[48]. In our study, however, sevoflurane administered
instead of propofol during reperfusion after successful
CPR did not further attenuate local cerebral inflamma-
tory response. These observations are comparable to
those obtained in a study by Fries et al. where the vola-
tile anesthetic isoflurane did not reduce neurological
dysfunction and histopathological alterations induced by
cardiac arrest [49]. However, it is conceivable that
hypothermia alone has such potent anti-inflammatory
properties compared to normothermia, that an addi-
tional effect of sevoflurane could not be revealed in the
present study. Moreover, potential protective effects of
volatile anesthetics depend on energy-dependent signal
transduction, for example, protein synthesis and phos-
phorylation [50], that may be affected by hypothermia-
induced decrease of metabolic rate as well as suppres-
sion of protein synthesis.
Cerebral apoptosis-related mRNA expression
In the cerebral cortex tissue, we found a significant upre-
gulation of both Bcl-2 and Bax mRNA expression after
global cerebral ischemia. Comparably, Mishra and collea-
gues have recently reported increased apoptosis in a pig
model of cerebral hypoxia for 60 minutes, indicated by
an increased ratio of Bax/Bcl-2 protein concentration,
activation of caspase-9, lipid peroxidation, and DNA frag-
mentation in mitochondria of the cerebral cortex [51].
Besides the regulation of inflammatory molecules,
mild therapeutic hypothermia significantly attenuated
the mRNA expression of the apoptosis-regulating pro-
teins Bax and Bcl-2 in our study. These results are
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[52,53], where hypothermia prevented an ischemia-
induced increase of the pro-apoptotic protein Bax, but
did not change or even increase expression of the anti-
apoptotic protein Bcl-2. Potential discrepancies between
the work presented here and those in the literature
could be due to the type of species and duration of
ischemia. In our pig model seven minutes of cardiac
arrest were followed by resuscitation compared with the
latter studies investigating a rat model of common caro-
tid artery occlusion plus hemorrhagic hypotension
[52,53]. In a similar rat model of cerebral ischemia, Pape
et al investigated the effects of sevoflurane on neuronal
damage and expression of apoptic factors. Sevoflurane
was administered before, during and after cerebral ische-
mia, and has been found to modulate the balance
between pro- and anti-apoptotic key proteins towards a
reduction of active programmed cell death by increasing
the hippocampal concentration of the anti-apoptotic
proteins Bcl-2, and by inhibiting the ischemia-induced
upregulation of the pro-apoptotic protein Bax [54].
In our pig model of cardiac arrest, however, sevoflur-
ane post-conditioning combined with mild hypothermia
did not confer additional effects in terms of apoptotic-
related mRNA expression. Again, it is conceivable that
hypothermia alone has such potent anti-apoptotic
effects, that an additional effect of sevoflurane could not
be revealed in the present study.
Limitations
Although we used a porcine model of cardiac arrest fol-
lowing myocardial ischemia reflecting a common clinical
scenario, there are several points that need to be
addressed in future studies: (i) both long-term survival
and neurological outcome were not evaluated because of
limitations posed by governmental regulations; therefore,
we did not assess the relationship between the upregula-
tion of cytokines and post-resuscitation cerebral dys-
function. (ii) Blinding the investigator was not possible
throughout the experiment due to the cooling techni-
que, but tissue samples were analyzed by a person
blinded to treatment assignment.
Conclusions
In conclusion, (i) global cerebral ischemia following car-
diac arrest results in up-regulation of pro-inflammatory
cytokines; (ii) hypothermia after cardiac arrest reduces
up-regulation of various cytokines in the cerebral tissue.
This may promote, at least in part, neuroprotection. (iii)
T h ev o l a t i l ea n e s t h e t i cs e v o f l u r a n e ,w h e na d m i n i s t e r e d
during reperfusion after successful CPR, did not confer
statistically significant additional anti-inflammatory
effects in the above setting.
Key messages
￿ Global cerebral ischemia following cardiac arrest
results in up-regulation of local pro-inflammatory
cytokines expression.
￿ Mild hypothermia after cardiac arrest attenuates
cerebral inflammatory response.
￿ Sevoflurane does not confer additional anti-inflam-
matory effects.
￿ Further studies on the relationship between cere-
bral inflammatory response and post-resuscitation
cerebral dysfunction are warranted.
Additional file 1: Extended Method section - Quantitative real-time
RT-PCR. Detailed description of quantitative real-time RT-PCR, primer
sequences and TaqMan probes.
Click here for file
[http://www.biomedcentral.com/content/supplementary/cc8879-S1.doc]
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